Recreational Exercising and Self-Reported Cardiometabolic Diseases in German People Living with HIV: A Cross-Sectional Study.
Camilo Germán Alberto Pérez ChaparroFelipe Barreto SchuchPhilipp ZechMaria KangasMichael A RappAndreas HeisselPublished in: International journal of environmental research and public health (2021)
Exercise is known for its beneficial effects on preventing cardiometabolic diseases (CMDs) in the general population. People living with the human immunodeficiency virus (PLWH) are prone to sedentarism, thus raising their already elevated risk of developing CMDs in comparison to individuals without HIV. The aim of this cross-sectional study was to determine if exercise is associated with reduced risk of self-reported CMDs in a German HIV-positive sample (n = 446). Participants completed a self-report survey to assess exercise levels, date of HIV diagnosis, CD4 cell count, antiretroviral therapy, and CMDs. Participants were classified into exercising or sedentary conditions. Generalized linear models with Poisson regression were conducted to assess the prevalence ratio (PR) of PLWH reporting a CMD. Exercising PLWH were less likely to report a heart arrhythmia for every increase in exercise duration (PR: 0.20: 95% CI: 0.10-0.62, p < 0.01) and diabetes mellitus for every increase in exercise session per week (PR: 0.40: 95% CI: 0.10-1, p < 0.01). Exercise frequency and duration are associated with a decreased risk of reporting arrhythmia and diabetes mellitus in PLWH. Further studies are needed to elucidate the mechanisms underlying exercise as a protective factor for CMDs in PLWH.
Keyphrases
- antiretroviral therapy
- hiv positive
- human immunodeficiency virus
- high intensity
- hiv infected
- physical activity
- hiv aids
- hiv infected patients
- men who have sex with men
- hepatitis c virus
- resistance training
- south africa
- stem cells
- heart failure
- clinical trial
- risk factors
- type diabetes
- bone marrow
- metabolic syndrome
- single cell
- hiv testing
- mesenchymal stem cells
- body composition
- peripheral blood
- adverse drug
- insulin resistance